Ki67, CD105 and α-smooth muscle actin expression in disease progression model of oral submucous fibrosis.

Amol Ramchandra GadbailMinal S ChaudharySachin Chakradhar Sarode Shailesh M GondivkarLalita BelekarMugdha P Mankar-GadbailRavi DandeSatyajit A TekadeMonal B Yuwanati Shankaragouda Patil

Published in: Journal of investigative and clinical dentistry (2019)

Ki67 LI, α-SMA and CD105 expression alone or together correspond with the disease progression model of SMF. Hence, expression of these markers can be used as a predictive marker of clinical outcome of OSCC-SMF.

Keyphrases

poor prognosis
smooth muscle
binding protein
neoadjuvant chemotherapy
long non coding rna
radiation therapy
nk cells